Empyrean Capital Partners’s TPG Pace Beneficial Finance Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share TPGY.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-500,000
Closed -$3.67M 193
2020
Q4
$3.67M Buy
+500,000
New +$2.83M 0.12% 98

Other funds holding TPGY.WS

Empyrean Capital Partners's TPGY.WS Position: Q1 2021 in Review

Empyrean Capital Partners sold out of TPG Pace Beneficial Finance Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (TPGY.WS) in Q1 2021, closing a stake of 500,000 shares — an estimated $3.67M sold.

Empyrean Capital Partners first reported a position in TPGY.WS in Q4 2020 and held it in 1 quarter. The position peaked at $3.67M in Q4 2020. 26 funds tracked by Wall St. Rank hold TPGY.WS as of Q1 2021.

  • Empyrean Capital Partners reported no remaining TPG Pace Beneficial Finance Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q1 2021 after selling out during the quarter.
  • Empyrean Capital Partners sold 500,000 TPG Pace Beneficial Finance Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q1 2021, an estimated $3.67M.
  • Empyrean Capital Partners first reported a position in TPG Pace Beneficial Finance Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q4 2020 and held it in 1 quarter.
  • Empyrean Capital Partners's TPG Pace Beneficial Finance Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $3.67M in Q4 2020.
  • 26 funds tracked by Wall St. Rank held TPG Pace Beneficial Finance Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q1 2021.

Based on Empyrean Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.